Schedule 13D ownership disclosure
AEROVATE THERAPEUTICS INC
Security class unavailable · CUSIP: 008064107
Event date: 2023-06-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,758,686
- Percent of class
- 13.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-025674
- Form type
- SC 13D
- Filer
- Jade Biosciences, Inc.
- CIK
- CIK 1798749
- Filed
- Feb 20, 2024
- Reporting period
- Jun 21, 2023
- Description
- Schedule 13D beneficial ownership